Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00879502 · ClinicalTrials.gov registry record
Examining Physiology and Brain Function in People With the Fragile X Premutation
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 110
- Enrollment target
NCT00879502: Completed study, sponsored by University of California, Davis.
NCT00879502 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00879502 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
This study will examine whether individuals with the fragile X genetic premutation are likely to have emotional, social, and memory deficits and how the brain may be involved in these deficits.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2007-06 |
| Est. Completion | 2013-02 |
What the finished NCT00879502 record still lists
NCT00879502 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00879502 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00879502 about?
NCT00879502 is a clinical study titled "Examining Physiology and Brain Function in People With the Fragile X Premutation". This study will examine whether individuals with the fragile X genetic premutation are likely to have emotional, social, and memory deficits and how the brain may be involved in these deficits.
What is the current status of trial NCT00879502?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2007-06. Estimated completion is 2013-02.
Who is sponsoring clinical trial NCT00879502?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia